Recent genetically engineered ccRCC mouse models together with emerging evidence from single cell RNA sequencing data open up for future validation studies, including multiplex imaging of ccRCC patient cohorts. These studies are of importance for therapy benefit and personalized treatment of ccRCC patients.
Keyphrases
- single cell
- end stage renal disease
- high throughput
- ejection fraction
- endothelial cells
- chronic kidney disease
- rna seq
- newly diagnosed
- mouse model
- high resolution
- case control
- prognostic factors
- case report
- peritoneal dialysis
- minimally invasive
- stem cells
- electronic health record
- current status
- patient reported outcomes
- machine learning
- cell therapy
- bone marrow
- artificial intelligence
- vascular endothelial growth factor